Centerbridge Partners LP is considering selling U.S. managed vision care benefits company Versant Health Inc., Reuters reported, citing people familiar with the matter.

The New York-based buyout firm has tapped Barclays PLC to manage the sales process of the company, which could notch a valuation of more than $2 billion, including debt, the sources said.

Other medical benefits providers and private equity firms could emerge as potential suitors of the business, the report noted.

Versant and Barclays did not comment on the potential deal, while Centerbridge did not answer Reuters' request for comment.